Form 4 for NMRA Neumora Therapeutics, Inc.
Accepted 2025-05-23 00:00:00 ET · period of report 2025-05-21 · accession 0001610717-25-000128 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-23 | 2025-05-21 | NMRA | Pinto Joshua | Pres | G - Gift | $0.00 | -13.2K | 63.8K | -17% | $0 | |
| I | 2025-05-23 | 2025-05-21 | NMRA | Pinto Joshua | Pres | G - Gift | $0.00 | +13.2K | 152.2K | +10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-21 | G | D | 13,202 | $0.00 | 63,750 | D See footnote | — | — | (F2) Shares held by Maple DE Holdings LLC, which is the entity defined above as "Family LLC". |
| 2 | Common | Common Stock | 2025-05-21 | G | A | 13,202 | $0.00 | 152,167 | I | — | — |